P

Inventor

PIAZZA GARY A

US62 patents
⚠️ This page may combine multiple inventors who share the name “PIAZZA GARY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELL PATHWAYS INC

36 patents
US6358992B1Mar 19, 2002

Method of inhibiting neoplastic cells with indole derivatives

CELL PATHWAYS INC125 citations98
US6133271AOct 17, 2000

Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives

CELL PATHWAYS INC92 citations98
US6348032B1Feb 19, 2002

Method of inhibiting neoplastic cells with benzimidazole derivatives

CELL PATHWAYS INC117 citations97
US6211177B1Apr 3, 2001

Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives

CELL PATHWAYS INC86 citations97
US6410584B1Jun 25, 2002

Method for inhibiting neoplastic cells with indole derivatives

CELL PATHWAYS INC46 citations96
US6200980B1Mar 13, 2001

Method of treating a patient having precancerous lesions with phenyl purinone derivatives

CELL PATHWAYS INC60 citations96
US5858694AJan 12, 1999

Method for identifying compounds for inhibition of cancerous lesions

CELL PATHWAYS INC60 citations96
US6500610B1Dec 31, 2002

Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compounds

CELL PATHWAYS INC22 citations93
US6486155B1Nov 26, 2002

Method of inhibiting neoplastic cells with isoquinoline derivatives

CELL PATHWAYS INC21 citations93
US6369092B1Apr 9, 2002

Method for treating neoplasia by exposure to substituted benzimidazole derivatives

CELL PATHWAYS INC32 citations93
US6232312B1May 15, 2001

Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides

CELL PATHWAYS INC31 citations93
US6034099AMar 7, 2000

Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones

CELL PATHWAYS INC21 citations93
US5942520AAug 24, 1999

Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines

CELL PATHWAYS INC27 citations93
US5852035ADec 22, 1998

Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines

CELL PATHWAYS INC28 citations93
US6180629B1Jan 30, 2001

[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia

CELL PATHWAYS INC28 citations92
US6121321ASep 19, 2000

Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions

CELL PATHWAYS INC26 citations92
US6071934AJun 6, 2000

Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions

CELL PATHWAYS INC25 citations92
US6063818AMay 16, 2000

Substituted benzylidene indenyl formamides, acetamides and propionamides

CELL PATHWAYS INC32 citations92
US5965619AOct 12, 1999

Method for treating patients having precancerous lesions with substituted indene derivatives

CELL PATHWAYS INC47 citations92
US6486158B1Nov 26, 2002

[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia

CELL PATHWAYS INC17 citations84
US6200771B1Mar 13, 2001

Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia

CELL PATHWAYS INC18 citations84
US6187779B1Feb 13, 2001

Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives

CELL PATHWAYS INC15 citations84
US6046199AApr 4, 2000

Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives

CELL PATHWAYS INC16 citations84
US6420410B1Jul 16, 2002

Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones

CELL PATHWAYS INC17 citations83
US6166053ADec 26, 2000

Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia

CELL PATHWAYS INC14 citations81
US6562830B1May 13, 2003

Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives

CELL PATHWAYS INC8 citations74
US6403831B1Jun 11, 2002

Substituted benzylidene indenyl formamides, acetamides and propionamides

CELL PATHWAYS INC13 citations74
US6300346B1Oct 9, 2001

Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions

CELL PATHWAYS INC7 citations74
US6211220B1Apr 3, 2001

Method for treating neoplasia with amino or pyridylamino cyclobutene derivatives

CELL PATHWAYS INC9 citations74
US6124303ASep 26, 2000

Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones

CELL PATHWAYS INC8 citations74
US6060477AMay 9, 2000

Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives

CELL PATHWAYS INC15 citations74
US6037345AMar 14, 2000

Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives

CELL PATHWAYS INC15 citations74
US6066634AMay 23, 2000

Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia

CELL PATHWAYS INC12 citations73
US5948779ASep 7, 1999

Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes

CELL PATHWAYS INC13 citations73
US6391885B1May 21, 2002

Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives

CELL PATHWAYS INC2 citations63
US6268372B1Jul 31, 2001

Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones

CELL PATHWAYS INC3 citations63

ADT PHARMACEUTICALS LLC

7 patents

PROCTER & GAMBLE

4 patents

ADT PHARMACEUTICALS INC

2 patents

OSI PHARM INC

1 patent

Showing the top 50 of 62 patents by PatentIndex Score.